SUZHOU FUSE BIOSCIENCES Trademark

Trademark Overview


On Friday, September 10, 2021, a trademark application was filed for SUZHOU FUSE BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the SUZHOU FUSE BIOSCIENCES trademark a serial number of 97021067. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 10, 2023. This trademark is owned by Suzhou Fuse Biosciences Limited. The SUZHOU FUSE BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes

Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical researc...
suzhou fuse biosciences

General Information


Serial Number97021067
Word MarkSUZHOU FUSE BIOSCIENCES
Filing DateFriday, September 10, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTherapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes
Goods and ServicesScientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuzhou Fuse Biosciences Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJiangsu 215128
CN

Trademark Events


Event DateEvent Description
Wednesday, December 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 10, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 10, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 10, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 15, 2022ASSIGNED TO EXAMINER
Tuesday, October 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 14, 2021NEW APPLICATION ENTERED